Filing Flows › Twist Bioscience (TWST) › DNA synthesis and protein solutions revenue
Twist Bioscience (TWST) DNA synthesis and protein solutions revenue by quarter
Twist Bioscience's DNA synthesis and protein solutions revenue was $56.6M in Q3 FY26 (third quarter fiscal 2026), +6% from Q2 FY26. Over the last 7 quarters it ranged from $5.3M (Q4 FY24) to $56.6M (Q3 FY26).
| Quarter | DNA synthesis and protein solutions revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $56.6M | +6% | +908% |
| Q2 FY26 | $53.3M | +4% | +835% |
| Q1 FY26 | $51.1M | +692% | — |
| Q4 FY25 | $6.4M | +15% | +22% |
| Q3 FY25 | $5.6M | -1% | — |
| Q2 FY25 | $5.7M | +8% | — |
| Q4 FY24 | $5.3M | — | — |
Q3 FY26 at a glance
Twist Bioscience, Q3 FY26: revenue $118M (+23% year over year), operating margin -30.6%, net loss $35.1M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Twist Bioscience's DNA synthesis and protein solutions revenue?
Twist Bioscience's DNA synthesis and protein solutions revenue was $56.6M in Q3 FY26 (third quarter fiscal 2026), +6% from Q2 FY26.
How has Twist Bioscience's DNA synthesis and protein solutions revenue changed?
Over the last 7 quarters it ranged from $5.3M (Q4 FY24) to $56.6M (Q3 FY26).